Moreover, Byrne et al. (2001) have reported that altered IHC-detected E-cadherin expression is significantly associated with disease progression and cancer-specific survival, and that E-cadherin and stage are independent predictors of disease progression. The gene discussed is CDH1; the disease is cancer.